🟢 Veracyte is trading 4.1% up today as Nasdaq rose 1.75%

Veracyte is trading 4.1% up at $41.43, most consistent with broader risk-on sentiment after the Nasdaq rose 1.75% and the S&P 500 gained 1.19%.

• No new company-specific announcement was identified on September 21, 2026.
• Veracyte’s latest official release was its September 14 acquisition of Convergent Genomics.
• Its September 15 Morgan Stanley presentation discussed growth, deals, and new tests.